Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it targets two incretin receptors instead of one
Their use is rising rapidly, and with good reason: These medications have been shown to reduce blood sugar, improve fatty liver, GERD, sleep apnea, osteoarthritis, blood pressure, triglycerides, major adverse cardiovascular events, and even show potential benefits for conditions like alcohol use disorder (Mozaffarian et al., 2025
Semaglutide and tirzeptide, in particular, have been in the news because of frequent shortages
In addition, the article reviews the clinical progress of GLP-1R agonists, including their efficacy, safety and potential in the treatment of diabetes and related complications
Asian Journal of Food and Agro-Industry, 3 (4), 389-397
US$ 22.89
US$ 27.74
US$ 28.99
US$ 24.15
US$ 26.42
US$ 26.02
